Zhejiang Huahai Pharmaceutical Co., Ltd.SSE: 600521

(600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Report for Q3 2026

· Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600521 · · 17 pages · Chinese

Summary by 6ix AI

The report highlights significant increases in revenue and profit compared to the same period last year, indicating strong business growth. The company assures the accuracy and completeness of the report's content, which has not been audited. Key financial metrics include total revenue and net profit attributed to shareholders, reflecting the company's operational success.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huahai Pharmaceutical

Later from Zhejiang Huahai Pharmaceutical

All Zhejiang Huahai Pharmaceutical news releases